CDK2 and glioblastoma: Consistent with concomitant EGFR and CDK2 inhibition, our gene expression data for differentiated GBM cells demonstrate that EMP3 KO leads to the downregulation of EGFR-responsive genes that are involved in DNA replication and cell cycle regulation.